• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1993 - 1997年乌干达坎帕拉的癌症生存率

Cancer survival in Kampala, Uganda, 1993-1997.

作者信息

Wabinga H, Parkin D M, Nambooze S, Amero J

机构信息

Kampala Cancer Registry, Department of Pathology, Makerere University Faculty of Medicine, Kampala, Uganda.

出版信息

IARC Sci Publ. 2011(162):243-7.

PMID:21675429
Abstract

The Kampala cancer registry was established in 1954 as a population-based cancer registry, and registration of cases is done by active methods. The registry contributed data on survival for 15 cancer sites or types registered in 1993-1997. For Kaposi sarcoma, only a random sample of the total incident cases was provided for survival study. Follow-up has been carried out predominantly by active methods, with median follow-up ranging from 4-26 months. The proportion with histologically verified diagnosis for various cancers ranged between 36-83%; death certificate only (DCO) cases were negligible; 58-92% of total registered cases were included for survival analysis. Complete follow-up at five years ranged between 47-87% for different cancers. Five-year age-standardized relative survival rates for selected cancers were Kaposi sarcoma (22%), cervix (19%), oesophagus (5%), non-Hodgkin lymphoma (26%), breast (36%) and prostate (46%). None survived beyond 5 years for cancers of the stomach and lung. Five-year relative survival by age group was fluctuating with no definite pattern or trend emerging and no survivors in many age intervals.

摘要

坎帕拉癌症登记处成立于1954年,是一个基于人群的癌症登记处,病例登记通过主动方式进行。该登记处提供了1993 - 1997年登记的15个癌症部位或类型的生存数据。对于卡波西肉瘤,仅提供了全部发病病例的随机样本用于生存研究。随访主要通过主动方式进行,中位随访时间为4 - 26个月。各种癌症经组织学证实诊断的比例在36% - 83%之间;仅死亡证明(DCO)的病例可忽略不计;纳入生存分析的登记病例总数的比例为58% - 92%。不同癌症的五年完全随访率在47% - 87%之间。选定癌症的五年年龄标准化相对生存率分别为:卡波西肉瘤(22%)、子宫颈癌(19%)、食管癌(5%)、非霍奇金淋巴瘤(26%)、乳腺癌(36%)和前列腺癌(46%)。胃癌和肺癌患者均无存活超过5年的。按年龄组划分的五年相对生存率波动不定,没有明确的模式或趋势,且在许多年龄区间没有幸存者。

相似文献

1
Cancer survival in Kampala, Uganda, 1993-1997.1993 - 1997年乌干达坎帕拉的癌症生存率
IARC Sci Publ. 2011(162):243-7.
2
Cancer survival in Harare, Zimbabwe, 1993-1997.1993 - 1997年津巴布韦哈拉雷的癌症生存率
IARC Sci Publ. 2011(162):249-55.
3
Cancer survival in Izmir, Turkey, 1995-1997.1995 - 1997年土耳其伊兹密尔的癌症生存率
IARC Sci Publ. 2011(162):237-42.
4
Cancer survival in the Gambia, 1993-1997.1993 - 1997年冈比亚的癌症生存率
IARC Sci Publ. 2011(162):97-100.
5
Cancer survival in Songkhla, Thailand, 1990-1999.泰国宋卡1990 - 1999年的癌症生存率。
IARC Sci Publ. 2011(162):227-35.
6
Cancer survival in Chiang Mai, Thailand, 1993-1997.泰国清迈1993 - 1997年癌症生存率。
IARC Sci Publ. 2011(162):199-209.
7
Cancer survival in Barshi, India, 1993-2000.印度巴尔希1993 - 2000年癌症生存率
IARC Sci Publ. 2011(162):101-6.
8
Cancer survival in Mumbai (Bombay), India, 1992-1999.1992 - 1999年印度孟买(旧称: Bombay)的癌症生存率。
IARC Sci Publ. 2011(162):133-42.
9
Cancer survival in Manila, Philippines, 1994-1995.1994 - 1995年菲律宾马尼拉的癌症生存率
IARC Sci Publ. 2011(162):147-50.
10
Cancer survival in Cuba, 1994-1995.1994 - 1995年古巴的癌症生存率
IARC Sci Publ. 2011(162):89-95.

引用本文的文献

1
Awareness of cervical cancer risk factors and preventive approaches, and perceived causes of cervical cancer among secondary school girls: a cross-sectional study in Northern Uganda.乌干达北部中学生对宫颈癌风险因素和预防方法的认知,以及对宫颈癌病因的认知:一项横断面研究。
Ann Med. 2024 Dec;56(1):2374860. doi: 10.1080/07853890.2024.2374860. Epub 2024 Jul 8.
2
Gastric cancer in Sub-Saharan Africa - a systematic review of primary data.撒哈拉以南非洲地区的胃癌——原始数据的系统综述
Ecancermedicalscience. 2024 Mar 7;18:1680. doi: 10.3332/ecancer.2024.1680. eCollection 2024.
3
Diagnostic and pre-treatment intervals among patients with cervical cancer attending care at the Uganda Cancer Institute: a cross-sectional study.
在乌干达癌症研究所接受治疗的宫颈癌患者的诊断和治疗前间隔:一项横断面研究。
BMC Womens Health. 2023 Nov 27;23(1):633. doi: 10.1186/s12905-023-02785-3.
4
Prognostic Factors for Overall Survival of Patients with Prostate Cancer in Kyadondo County, Uganda.乌干达Kyadondo县前列腺癌患者总生存的预后因素
Prostate Cancer. 2020 Jan 27;2020:8517130. doi: 10.1155/2020/8517130. eCollection 2020.
5
Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisal.评估为《2008年全球癌症统计》提供数据的撒哈拉以南非洲癌症登记系统的质量:文献综述与批判性评价
J R Soc Med. 2015 Feb;108(2):57-67. doi: 10.1177/0141076814554671.
6
Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.非洲裔女性三阴性乳腺癌的流行病学、生物学特性及治疗
Lancet Oncol. 2014 Dec;15(13):e625-e634. doi: 10.1016/S1470-2045(14)70364-X. Epub 2014 Nov 24.
7
Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy.埃塞俄比亚的宫颈癌:接受肿瘤治疗的 1059 名患者的生存情况。
Oncologist. 2014 Jul;19(7):727-34. doi: 10.1634/theoncologist.2013-0326. Epub 2014 Jun 20.
8
Early experience after developing a pathology laboratory in Malawi, with emphasis on cancer diagnoses.马拉维建立病理实验室后的早期经验,重点是癌症诊断。
PLoS One. 2013 Aug 7;8(8):e70361. doi: 10.1371/journal.pone.0070361. eCollection 2013.
9
Breast cancer knowledge and awareness among university students in Angola.安哥拉大学生对乳腺癌的知识与认知
Pan Afr Med J. 2012;11:70. Epub 2012 Apr 16.
10
Cancer incidence in Nigeria: a report from population-based cancer registries.尼日利亚的癌症发病率:基于人群的癌症登记处的报告。
Cancer Epidemiol. 2012 Oct;36(5):e271-8. doi: 10.1016/j.canep.2012.04.007. Epub 2012 May 22.